Literature DB >> 11242548

Telephone management in substance abuse treatment.

J A Hall1, D L Huber.   

Abstract

The purpose of this article is to describe the results of a clinical trial in which telephonic case management was evaluated as a supplement to substance abuse treatment. An interactive voice response system (IVR) was developed by the research team for use in the case management of randomly assigned participants in a clinical trial research project. The features of the software program facilitated a double caseload for the case manager as well as real-time data capture. At intake, no significant differences were found between participants in the telecommunication condition and the general project. Thus, the effectiveness of random assignment was supported. An IVR was useful for case management services, was less costly, and showed acceptability to clients. A reduction in time expenditure by using telecommunication occurred within three activity areas. Telecommunication facilitated client interaction and the use of case management, and it reduced provider time expenditure. As an alternative strategy, telecommunication case management can enhance cost effectiveness improvements.

Entities:  

Mesh:

Year:  2000        PMID: 11242548     DOI: 10.1089/15305620050503870

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  13 in total

Review 1.  Computer-based interventions for drug use disorders: a systematic review.

Authors:  Brent A Moore; Tera Fazzino; Brian Garnet; Christopher J Cutter; Declan T Barry
Journal:  J Subst Abuse Treat       Date:  2010-12-24

2.  Iowa Case Management for Rural Drug Abuse.

Authors:  James A Hall; Mary S Vaughan Sarrazin; Diane L Huber; Thomas Vaughn; Robert I Block; Amanda R Reedy; Mijin Jang
Journal:  Res Soc Work Pract       Date:  2009-07

3.  A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use.

Authors:  Brent A Moore; Frank D Buono; Daniel P Lloyd; Destiny M B Printz; David A Fiellin; Declan T Barry
Journal:  J Subst Abuse Treat       Date:  2018-11-24

4.  Customized recommendations and reminder text messages for automated, computer-based treatment during methadone.

Authors:  Brent A Moore; Frank D Buono; Destiny M B Printz; Daniel P Lloyd; David A Fiellin; Christopher J Cutter; Richard S Schottenfeld; Declan T Barry
Journal:  Exp Clin Psychopharmacol       Date:  2017-12       Impact factor: 3.157

5.  Efficacy of automated telephone continuing care following outpatient therapy for alcohol dependence.

Authors:  Gail L Rose; Joan M Skelly; Gary J Badger; Tonya A Ferraro; John E Helzer
Journal:  Addict Behav       Date:  2014-10-30       Impact factor: 3.913

6.  Interactive voice response technology can deliver alcohol screening and brief intervention in primary care.

Authors:  Gail L Rose; Charles D MacLean; Joan Skelly; Gary J Badger; Tonya A Ferraro; John E Helzer
Journal:  J Gen Intern Med       Date:  2010-02-02       Impact factor: 5.128

7.  Effectiveness of Remote Intensive Counseling Versus Outpatient Counseling in Substance Use Disorders: A Retrospective Cohort Study.

Authors:  Armand Ntchana; Ricky Daley
Journal:  Cureus       Date:  2022-04-15

8.  Cognitive-behavioral therapy in depressed primary care patients with co-occurring problematic alcohol use: effect of telephone-administered vs. face-to-face treatment-a secondary analysis.

Authors:  Raj K Kalapatapu; Joyce Ho; Xuan Cai; Sophia Vinogradov; Steven L Batki; David C Mohr
Journal:  J Psychoactive Drugs       Date:  2014 Apr-Jun

Review 9.  Interactive voice response technology for symptom monitoring and as an adjunct to the treatment of chronic pain.

Authors:  Gregory Lieberman; Magdalena R Naylor
Journal:  Transl Behav Med       Date:  2012-03       Impact factor: 3.046

Review 10.  Non-adherence to telemedicine interventions for drug users: systematic review.

Authors:  Taís de Campos Moreira; Luciana Signor; Luciana Rizzieri Figueiró; Simone Fernandes; Cassandra Borges Bortolon; Mariana Canellas Benchaya; Maristela Ferigolo; Helena Mt Barros
Journal:  Rev Saude Publica       Date:  2014-06       Impact factor: 2.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.